Last reviewed · How we verify
Harvesting of muscular biopsies
Harvesting of muscular biopsies is a Biologic drug developed by I.R.C.C.S Ospedale Galeazzi-Sant'Ambrogio. It is currently in Phase 2 development.
At a glance
| Generic name | Harvesting of muscular biopsies |
|---|---|
| Sponsor | I.R.C.C.S Ospedale Galeazzi-Sant'Ambrogio |
| Modality | Biologic |
| Phase | Phase 2 |
Approved indications
Common side effects
Key clinical trials
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Harvesting of muscular biopsies CI brief — competitive landscape report
- Harvesting of muscular biopsies updates RSS · CI watch RSS
- I.R.C.C.S Ospedale Galeazzi-Sant'Ambrogio portfolio CI
Frequently asked questions about Harvesting of muscular biopsies
What is Harvesting of muscular biopsies?
Harvesting of muscular biopsies is a Biologic drug developed by I.R.C.C.S Ospedale Galeazzi-Sant'Ambrogio.
Who makes Harvesting of muscular biopsies?
Harvesting of muscular biopsies is developed by I.R.C.C.S Ospedale Galeazzi-Sant'Ambrogio (see full I.R.C.C.S Ospedale Galeazzi-Sant'Ambrogio pipeline at /company/i-r-c-c-s-ospedale-galeazzi-sant-ambrogio).
What development phase is Harvesting of muscular biopsies in?
Harvesting of muscular biopsies is in Phase 2.